BCRX - BioCryst Pharmaceuticals, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
BioCryst Pharmaceuticals, Inc.
Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.
IPO Date: March 4, 1994
Sector: Healthcare
Industry: Biotech
Market Cap: $2.06B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 3.36%
Avg Daily Range (30 D): $0.21 | 2.34%
Avg Daily Range (90 D): $0.22 | 2.32%
Institutional Daily Volume
Avg Daily Volume: 1.66M
Avg Daily Volume (30 D): 3.95M
Avg Daily Volume (90 D): 3.65M
Trade Size
Avg Trade Size (Sh.): 174
Avg Trade Size (Sh.) (30 D): 131
Avg Trade Size (Sh.) (90 D): 125
Institutional Trades
Total Institutional Trades: 4,569
Avg Institutional Trade: $2.36M
Avg Institutional Trade (30 D): $3.84M
Avg Institutional Trade (90 D): $3.51M
Avg Institutional Trade Volume: .29M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.46M
Avg Closing Trade (30 D): $8.03M
Avg Closing Trade (90 D): $7.12M
Avg Closing Volume: 415.85K
 
News
Sep 18, 2026 @ 4:31 PM
4 Biotech Stocks to Watch as Potential Takeover Ta...
Source: Na
Aug 25, 2026 @ 11:01 AM
BioCryst Announces Approval of ORLADEYO® for Pe...
Source: Biocryst Pharmaceuticals, Inc.
Jun 12, 2026 @ 11:00 AM
BioCryst Presents New Clinical Data and Real-World...
Source: Biocryst Pharmaceuticals, Inc.
May 6, 2026 @ 11:00 AM
BioCryst Reports First Quarter 2026 Financial Resu...
Source: Biocryst Pharmaceuticals, Inc.
May 4, 2026 @ 11:00 AM
BioCryst Announces European Licensing Agreement wi...
Source: Na